• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    More On PAB.AX



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Patrys Limited (PAB.AX)

    0.01 0.00(0.00%) Jun 26
    ProfileGet Profile for:
    Patrys Limited
    100 Albert Road
    Level 4
    South Melbourne, VIC 3205
    Australia - Map
    Phone: 61 3 9670 3273
    Fax: 61 3 9670 3247
    Website: http://www.patrys.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Patrys Limited, together with its subsidiaries, develops natural human antibody therapeutics for the treatment of cancer in Australia. The company’s clinical products include PAT-SM6, a natural human antibody used for the treatment of various types of cancer, including solid tumors, such as melanoma, breast, colon, and pancreatic, as well as blood-based cancers that include multiple myeloma; and PAT-SC1, an antibody for treating gastric cancer. Its late stage preclinical products comprise PAT-LM1, a natural human antibody, which is used in the treatment of colon, lung, breast, ovary, and pancreatic cancers. The company was founded in 2006 and is based in South Melbourne, Australia.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Patrys Limited

    Key Executives 
    Dr. James A. Campbell BSc, Ph.D., MBA,
    Chief Exec. Officer, Managing Director and Director
    Dr. Deanne Greenwood Ph.D., MBA,
    VP of Bus. Devel. & Intellectual Property
    Ms. Melanie Jaye Leydin B.Bus (Acc/Law), CA, 43
    Company Sec.
    Ms. Valentina Dubljevic MBB, BSc ,
    VP of Scientific & Clinical Devel.
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in AUD.